• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型神经纤维瘤病合并视神经胶质瘤患儿的生长激素过多症

Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.

作者信息

Cambiaso Paola, Galassi Stefania, Palmiero Melania, Mastronuzzi Angela, Del Bufalo Francesca, Capolino Rossella, Cacchione Antonella, Buonuomo Paola S, Gonfiantini Michaela V, Bartuli Andrea, Cappa Marco, Macchiaiolo Marina

机构信息

Endocrinology and Diabetes Unit, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.

Neuroradiology Unit, Bambino Gesù Children Hospital, Imaging Department, IRCCS, Rome, Italy.

出版信息

Am J Med Genet A. 2017 Sep;173(9):2353-2358. doi: 10.1002/ajmg.a.38308. Epub 2017 Jun 20.

DOI:10.1002/ajmg.a.38308
PMID:28631895
Abstract

In children with neurofibromatosis type 1 (NF1) and optic pathways glioma (OPG), growth hormone (GH) excess has been rarely reported and mainly associated to central precocious puberty. The aim of our study is to evaluate the prevalence of GH excess, the association with central precocious puberty, the relation with tumor site and the evolution over time in a large cohort of children with NF1 and OPG. Sixty-four NF1 children with OPG were evaluated. Patients with stature and/or height velocity >2 SD for age were studied for GH secretion. Seven out of 64 children (10.9%) with NF1 and optic pathways glioma showed GH excess, isolated in 5 cases and associated to central precocious puberty in 2. All the children with GH excess had a tumor involving the chiasma. Children with GH excess underwent medical treatment with lanreotide and a minimum clinical/biochemical follow up of 2 years is reported. The present study demonstrates that GH excess should be considered as a relative frequent endocrine manifestation in NF1 patients, similarly to central precocious puberty. Therefore, these patients should undergo frequent accurate auxologic evaluations. On the other hand, an increase in height velocity in children with NF1, even despite normal ophthalmological exams, can suggest the presence of OPG and therefore represents an indication to perform brain MRI.

摘要

在患有1型神经纤维瘤病(NF1)和视路胶质瘤(OPG)的儿童中,生长激素(GH)分泌过多的情况鲜有报道,且主要与中枢性性早熟相关。我们研究的目的是评估一大群患有NF1和OPG的儿童中GH分泌过多的患病率、与中枢性性早熟的关联、与肿瘤部位的关系以及随时间的演变情况。对64例患有OPG的NF1儿童进行了评估。对身高和/或身高增长速度高于年龄标准差2倍的患者进行了GH分泌研究。64例患有NF1和视路胶质瘤的儿童中有7例(10.9%)出现GH分泌过多,其中5例为单纯性,2例与中枢性性早熟相关。所有GH分泌过多的儿童都有累及视交叉的肿瘤。GH分泌过多的儿童接受了兰瑞肽药物治疗,并报告了至少2年的临床/生化随访情况。本研究表明,与中枢性性早熟类似,GH分泌过多应被视为NF1患者相对常见的内分泌表现。因此,这些患者应接受频繁而准确的体格检查评估。另一方面,NF1儿童即使眼科检查正常,但身高增长速度加快也可能提示存在OPG,因此这是进行脑部MRI检查的一个指征。

相似文献

1
Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.1型神经纤维瘤病合并视神经胶质瘤患儿的生长激素过多症
Am J Med Genet A. 2017 Sep;173(9):2353-2358. doi: 10.1002/ajmg.a.38308. Epub 2017 Jun 20.
2
Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients.1型神经纤维瘤病患儿的性早熟和青春期加速:45例患者队列的密切随访结果
Hormones (Athens). 2023 Mar;22(1):79-85. doi: 10.1007/s42000-022-00411-9. Epub 2022 Oct 21.
3
Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.一名携带NF1基因R681X突变的1型神经纤维瘤病女孩的视神经胶质瘤和性早熟:病例报告及文献复习
BMC Endocr Disord. 2015 Dec 15;15:82. doi: 10.1186/s12902-015-0076-4.
4
Gigantism due to growth hormone excess in a boy with optic glioma.
Clin Endocrinol (Oxf). 2000 Oct;53(4):535-8. doi: 10.1046/j.1365-2265.2000.01041.x.
5
Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.神经纤维瘤病 1 患者未选择队列视神经通路胶质瘤的自然史。
J Neurooncol. 2017 Sep;134(2):279-287. doi: 10.1007/s11060-017-2517-6. Epub 2017 Jun 2.
6
Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.儿童 1 型神经纤维瘤病伴视路胶质瘤的预处理内分泌紊乱:多中心研究。
J Clin Endocrinol Metab. 2020 Jun 1;105(6). doi: 10.1210/clinem/dgaa138.
7
Reversible Growth Hormone Excess in Two Girls with Neurofibromatosis Type 1 and Optic Pathway Glioma.两名患有1型神经纤维瘤病和视路胶质瘤的女孩出现可逆性生长激素过多症。
Horm Res Paediatr. 2015;84(6):414-22. doi: 10.1159/000440956. Epub 2015 Oct 22.
8
Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.1型神经纤维瘤病患者的视路胶质瘤:44例患者的随访
J AAPOS. 2010 Apr;14(2):155-8. doi: 10.1016/j.jaapos.2009.11.020.
9
Optic Pathway Gliomas in Neurofibromatosis Type 1.1型神经纤维瘤病中的视路胶质瘤
J Child Neurol. 2018 Jan;33(1):73-81. doi: 10.1177/0883073817739509.
10
Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.1型神经纤维瘤病患儿的内分泌紊乱与视路胶质瘤
Pediatrics. 1997 Oct;100(4):667-70. doi: 10.1542/peds.100.4.667.

引用本文的文献

1
Aryl hydrocarbon receptor interacting protein and syndromic gene variants detected in Turkish isolated pituitary adenoma families by whole exome sequencing.通过全外显子组测序在土耳其孤立性垂体腺瘤家族中检测到的芳烃受体相互作用蛋白和综合征基因变异
Sci Rep. 2025 Jul 7;15(1):24279. doi: 10.1038/s41598-025-08610-1.
2
Association of pituitary neuroendocrine tumors and neurofibromatosis type 1: assessing causation versus coincidence. Case report.垂体神经内分泌肿瘤与1型神经纤维瘤病的关联:评估因果关系与巧合。病例报告。
Front Endocrinol (Lausanne). 2025 Feb 4;16:1483305. doi: 10.3389/fendo.2025.1483305. eCollection 2025.
3
Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder.
揭开肢端肥大症的遗传奥秘:探索遗传学在一种罕见疾病中的作用。
Curr Issues Mol Biol. 2024 Aug 20;46(8):9093-9121. doi: 10.3390/cimb46080538.
4
Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.成年 1 型神经纤维瘤病患者疲劳的内分泌和非内分泌原因。
Front Endocrinol (Lausanne). 2024 Mar 15;14:1119159. doi: 10.3389/fendo.2023.1119159. eCollection 2023.
5
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases.儿童和青少年垂体腺瘤的诊断和管理共识指南:第 2 部分,特定疾病。
Nat Rev Endocrinol. 2024 May;20(5):290-309. doi: 10.1038/s41574-023-00949-7. Epub 2024 Feb 9.
6
A new era for optic pathway glioma: A developmental brain tumor with life-long health consequences.视神经通路胶质瘤的新时代:一种对终生健康有影响的发育性脑肿瘤。
Front Pediatr. 2023 Mar 24;11:1038937. doi: 10.3389/fped.2023.1038937. eCollection 2023.
7
Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype-Phenotype Correlations.1型神经纤维瘤病:儿科方面及基因型-表型相关性综述
Cancers (Basel). 2023 Feb 14;15(4):1217. doi: 10.3390/cancers15041217.
8
The Spectrum of Familial Pituitary Neuroendocrine Tumors.家族性垂体神经内分泌肿瘤谱系
Endocr Pathol. 2023 Mar;34(1):57-78. doi: 10.1007/s12022-022-09742-0. Epub 2022 Nov 18.
9
Management of Optic Pathway Glioma: A Systematic Review and Meta-Analysis.视路胶质瘤的管理:一项系统评价与荟萃分析
Cancers (Basel). 2022 Sep 30;14(19):4781. doi: 10.3390/cancers14194781.
10
Ovarian cell tumor in a child with neurofibromatosis type 1.儿童 1 型神经纤维瘤病伴卵巢细胞瘤。
Ann Afr Med. 2022 Apr-Jun;21(2):165-167. doi: 10.4103/aam.aam_93_20.